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In Brief
Radiation injury to the brain remains a
common problem among cancer
survivors, leading to significant
deterioration in quality of life. A key long-
term consequence of radiation is diffuse
demyelination. Piao et al. derive
oligodendrocyte progenitors from hPSCs
and demonstrate that engrafted cells
restore myelination and behavioral
defects of irradiated rats.
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Radiation therapy to the brain is a powerful tool in the
management of many cancers, but it is associated
with significant and irreversible long-term side ef-
fects, including cognitive decline and impairment
of motor coordination. Depletion of oligodendrocyte
progenitors and demyelination are major patholog-
ical features that are particularly pronounced in
younger individuals and severely limit therapeutic
options. Herewe testedwhether human ESC-derived
oligodendrocytes can functionally remyelinate the
irradiated brain using a rat model. We demonstrate
the efficient derivation and prospective isolation of
human oligodendrocyte progenitors, which, upon
transplantation, migrate throughout the major white
matter tracts resulting in both structural and func-
tional repair. Behavioral testing showed complete
recovery of cognitive function while additional recov-
ery from motor deficits required concomitant trans-
plantation into the cerebellum. The ability to repair
radiation-induced damage to the brain could dramat-
ically improve the outlook for cancer survivors and
enable more effective use of radiation therapies,
especially in children.
INTRODUCTION
The ability to direct pluripotent stem cells (hPSC) into specific
fates has raised hopes of translating these efforts into effective
therapies. There has been notable progress in the neural field,
where several therapeutically relevant cell types have been
derived using greatly improved and highly reproducible proto-
cols (Tabar and Studer, 2014). The derivation of engraftable
glia has also been reported and the most recent studies
have convincingly demonstrated the ability of human pluripotent
stem-cell-derived oligodendrocytes to achieve extensive myeli-198 Cell Stem Cell 16, 198–210, February 5, 2015 ª2015 Elsevier Incnation in vivo following transplantation into neonatal Shiverer
mice (Hu et al., 2009, Wang et al., 2013; Douvaras et al. 2014).
These are promising data, though oligodendrocyte differentia-
tion protocols remain complex and protracted, and applications
have not been tested much beyond this genetic neonatal model.
Here, we present a novel indication for human PSC-derived
oligodendrocytes, namely the repair of diffuse demyelination
occurring as a consequence of radiation injury to the brain, a clin-
ically important but largely unmet need among cancer survivors.
Radiation therapy to the brain is a commonly prescribed treat-
ment for many cancers, including primary and metastatic brain
tumors, as well as in prophylactic regimens in small cell cancers
(Paumier et al., 2011) or leukemia (Gibbs et al., 2006). It is often
associated with significant long-term cognitive symptoms, even
at standard doses and using modern techniques (Greene-
Schloesser et al., 2012). Progressive impairments in memory,
attention, executive function, and motor coordination are des-
cribed, as well as learning difficulties and a decrease in intelli-
gence quotients (IQ) in children (Schatz et al., 2000). The clinical
course is often progressive and irreversible, and there is no
effective treatment for radiation-induced cognitive decline.
Nevertheless, the use of high volume CNS radiation continues
to be a therapeutic cornerstone in many cancers, for palliative
or curative purposes (Ringborg et al., 2003). The pathogenesis
of the late effects (months to years) of radiation is not completely
understood, and studies in animals and humans support an
important role for the depletion of the oligodendrocyte precursor
pool and subsequent demyelination (Kurita et al., 2001; Oi et al.,
1990; Panagiotakos et al., 2007). In addition to autopsy data,
there is increasing evidence from recent diffusion tensor imaging
studies that support the premise that radiation results in early
and progressive damage to the white matter and that the latter’s
integrity correlates with intellectual outcome (Mabbott et al.,
2006; Uh et al., 2013). Other areas of potential injury include
the vascular compartment, whereby thrombosis and hyaliniza-
tion can be seen subacutely, particularly following high doses
of radiation (Duffner et al., 1985), as well as the subventricular
zone (SVZ) and hippocampus where transit amplifying and/or
neural stem cells reside (Monje et al., 2002, 2003). However, it
is evident that the plethora of radiation-related symptoms cannot.
be solely attributed to the disruption of neurogenesis in the hip-
pocampus and the SVZ, especially in humans. Data from our lab
and others demonstrate that radiation extensively targets the
large pool of mitotically active oligodendrocyte progenitors.
These cells are acutely reduced in number and eventually
depleted, followed by progressive, often patchy, demyelination
(Sano et al., 2000; Panagiotakos et al., 2007). Here, we model
the effects of radiation in young rats, using a clinically relevant
fractionated regimen of 50 Gy to the whole brain. Our data
show depletion of the oligodendrocyte pool and a delayed
onset of demyelination, as well as cognitive and motor deficits.
Concomitantly, we optimize a protocol for the derivation and
selective enrichment of late oligodendrocyte progenitors (O4-ex-
pressing) from human embryonic stem cells (ESCs) and demon-
strate that these cells can remyelinate the brain and ameliorate
behavioral deficits. The clinical impact of these studies can be
substantial as the need to address quality of life in cancer survi-
vors grows more pressing.
RESULTS
Impact of Radiation on the Young Rat Brain
We subjected 4-week-old Sprague-Dawley rats to a dose of
50 Gy of radiation, administered in 10 fractions to the whole
brain. Analysis of the brains at 14 weeks demonstrated a signif-
icant decrease in the number of oligodendrocyte progenitors
throughout the brain as determined by the number of oligoden-
drocyte transcription factor 2 (olig2)-expressing cells and the
decrease in O4 expression (Figure 1A; Figure S1A). This was
associated with a decrease in myelin basic protein (MBP)
expression and in the volume of the corpus callosum by
25%, as determined by stereological volume analysis. The
loss of MBP encompassed all major white matter pathways
including the corpus callosum, the hippocampal fimbria, the
commissures, as well as the subcortical areas and the cere-
bellum (Figure 1B; Figure S1A). The irradiated brain showed
mild evidence of an inflammatory response demonstrated by
an increase in the number of activated microglial/macrophages
(ED1/Iba-1), and no significant gliosis at 14 weeks after radiation
(Figure S1B). Behavioral testing was conducted on the irradiated
and the normal age-matched groups. It consisted of cognitive
and memory tests, including novel object preference and object
location tasks, as well as water maze and rotarod testing with
acceleration conditions. The data showed a significant decline
in performance on the novel object preference and object loca-
tion tasks (Barker et al., 2007), as well as a decrease in the dura-
tion of time spent on the rotarod wheel (from 11.8 to 2.2 s) and a
substantial decrease in the distance traversed during that test
(from 1 m to 0.18 m) (Figures 1C and 1D). The water maze
task did not result in a statistically significant difference in either
the time spent or distance traveled in the target quadrant in
probe test, as previously reported (Saxe et al., 2006; Vorhees
and Williams, 2006) (Figure S1C).
Derivation of Late Oligodendrocyte Progenitors from
Human Embryonic Stem Cells
Recent advances in the field of human pluripotent stem cell
biology have led to highly robust protocols for neural differentia-
tion and specification into various neural and non-neural fates.CeHowever, the oligodendrocyte lineage has been a long-standing
challenge in the field, due to the requirement for lengthy in vitro
differentiation periods (Wang et al., 2013; Douvaras et al.
2014), perhaps compatible with the protracted developmental
timeline followed in utero. We optimized a human pluripotent
stem cell protocol that allows the derivation of well characterized
oligodendrocyte progenitors by 70 days in vitro (DIV) through
several stages, including neural induction, patterning of neural
precursors, oligodendrocyte progenitor proliferation, and differ-
entiation (Figure 1E). Undifferentiated hESCs were subjected
to neural induction by dual SMAD and Wnt/b-catenin inhibition
using LDN193189 (LDN), SB431542 (SB), and XAV939 (XAV)
(Chambers et al., 2009), resulting in the emergence of ZO-1/
LIN-28/Nestin-expressing CNS neural rosettes. Neural precur-
sors emerging from rosettes express Pax6 and FOXG1, suggest-
ing an anterior forebrain identity; they are replated in the pres-
ence of purmorphamine, a smoothened agonist that activates
the hedgehog pathway. Cells are then passaged in the presence
of FGF8, and on DIV 40, they are exposed to glial media con-
taining PDGFRa, IGF-1, cAMP, and T3. Early oligodendrocyte
progenitors are observed in the culture on day 45 and are
characterized by NKx2.2/Olig2/PDGFRa expression (Figure 1F).
PDGFRa+ progenitors are highly proliferative (Ki-67 of 57%)
and co-label for Sox10 (Figures S1D and S1E). Their proportion
in the culture increases steadily from an average of 6% to 25%
on DIV 100 (Figures S1F and S1G). Late oligodendrocyte pro-
genitors (O4-expressing) emerge by DIV 50, increasing steadily
to 35% by DIV 100, while maintaining expression of Olig2,
Nkx2.2, and Sox10 (Figure 1F; Figures S2A and S2B). These cells
mature in overlapping waves, leading to the gradual appearance
of oligodendrocytes that express O1 and MBP. Further in vitro
maturation of the majority of the cells (>85%) is achieved by
exposure to differentiation media (BDNF, AA, T3, and cAMP)
for 2 weeks, leading to morphologically mature oligodendro-
cytes that express O1, myelin-associated glycoproteins such
as MOG and MAG, and MBP (Figure 1G). FACS sorting for late
oligodendrocyte progenitors (O4 expressing) (Figure S2C) leads
to highly enriched cultures with >93% of cells expressing O4 (re-
maining cells are olig2+, data not shown) and co-labeling for
Olig2 and Nkx2.2; the majority of those cells are post-mitotic
(Ki-67 of 3%) (Figure S2B). Efficient sorting can be performed
on DIV 70 or later.
We further characterized the O4+ sorted cells by global tran-
scriptomal analysis (Figures S2D and S2E). Comparison of the
expression profile of O4-enriched day 70 cells with that of undif-
ferentiated H9 ESCs, showed the robust induction of transcrip-
tion factors related to oligodendrocyte identity such as OLIG1,
OLIG2, and SOX10, Nkx2.2, as well significant expression of
myelin-related genes MAG, OMG, and MBP. A telencephalic
identity was suggested by the upregulation of FOXG1, OTX1,
EMX2, and LHX2 forebrain markers and the absence of Hox
genes (Figure 1H). RTqPCR (Figure 1I) further validated >104-
fold change in transcription factors that are master regulators
of the oligodendrocyte fate. Functional annotation of enriched
gene sets was also compatible with glial and oligodendroglial
development (Figure S2F).
To verify the reproducibility of the protocol for oligodendrocyte
differentiation, we tested an additional hES line, WA-07 and two
iPSC lines, J1 and J2. The iPSC lines were derived fromll Stem Cell 16, 198–210, February 5, 2015 ª2015 Elsevier Inc. 199
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fibroblasts of a healthy young donor (J1) and an old donor (J2),
and were reprogrammed using Sendai vectors (Miller et al.,
2013). All tested lines were capable of oligodendrocyte deriva-
tion using the same protocol. Enrichment for O4+ cells on DIV
70 shows a range of 10%–20% O4+ OPC in the cultures. The
sorted cells from all three additional lines (H7, J1, and J2) ex-
pressed appropriate OPC markers (Olig2, Nkx2.2, Sox10), and
exhibited a similar pattern of differentiation and expression of
mature markers, e.g., MBP (Figures 2A and 2B). Evidence for
myelination of axons was assessed in co-cultures of O4+
OPCs derived from each of the 2 hES and 2 iPSC lines, with hu-
man ES-derived neurons or young rat hippocampal neurons
(Figure 2C; Figure S3A). After 5 weeks in vitro, the cultures ex-
hibited myelin sheaths along the axons (identified by SMI 312
immunoreactivity); the length of ensheathed/myelinated axons
per oligodendrocyte was quantified and found to be similar
across the four pluripotent cell lines (Figure 2D). Electron micro-
scopy sections demonstrated the presence of compact myelin
sheaths with dense lines (Figure 2E). The cultures did not exhibit
any spontaneous or endogenous myelination under control con-
ditions (Figure S3B).
Grafted Human ESC-Derived Oligodendrocytes
Remyelinate the Irradiated Brain and Ameliorate
Cognitive Function
We then asked whether the human ESC-derived oligodendro-
cytes could succeed in restoring myelination in the irradiated
brains. We thus irradiated a set of 10 nude rats using the same
regimen of 50 Gy in 10 fractions, followed by behavioral testing
for novel object preference, object location recognition, and ro-
tarod (with acceleration) performance. At 4 weeks post-radia-
tion, the rats (XRT+ graft group) received bilateral stereotactic
injections of human ESC-derived oligodendrocytes into the
corpus callosum (2 injections per cerebral hemisphere, for a total
of 1 million cells). The injected cells were enriched for O4 expres-
sion via FACS on DIV 100 (35.7% ± 10.62 of the cells were O4+
pre-sort), immediately prior to grafting. Control groups consisted
of non-irradiated animals (control group) and sham injections of
Hanks’ balanced salt solution (HBSS) into irradiated (XRT group)
rats.
Serial behavioral testing was performed on all animals. It con-
sisted of the novel object preference and object location tasks,Figure 1. Impact of Radiation on the Rat Brain and Derivation of Oligo
(A) Immunohistochemistry shows a decrease in O4 levels and in the number of O
(B) A decrease in expression of MBP is noted in various brain regions 14 weeks
(C)When compared to age-matched controls (n = 4), irradiated rats (XRT, n = 5) exh
the discrimination ratio in the object location task.
(D) The rotarod test also shows a significant decrease in the time spent and the
(E) Schematic protocol for differentiation of human pluripotent stem cells into OP
(F) Immunocytochemical characterization of hES-derived progenitors at progressi
co-express PDGFRawith Olig2 and Nkx2.2. By day 70, late OPCs emerge, expre
expression also increases as the cells mature; by day 85, they express myelin as
(G) When placed in differentiation media for 2 weeks, day 70-O4+ cells will matu
(H) List of selected increased anterior oligospecific genes comparing O4-sorted
analysis.
(I) qRT-PCR analysis of O4 sorted late OPCs at day 70 showed an increase in olig
specific markers (FoxG1, OTX1, EMX2) compared to the undifferentiated hES co
All panels in (A) and (B) (except for ‘‘cerebellum’’ images) are composites of sever
SEM. (*p < 0.05. **p < 0.01). Circles in (C) and (D) represent individual scores. Al
Ceas well as rotarod testing. While the XRT group continued to
exhibit poor performance compared to age-matched normal
rats, the irradiated but grafted group demonstrated statistically
significant improvements in novel object preference and object
location recognition parameters, at 10 weeks after transplanta-
tion (Figures 3A and 3B). These tasks reflect multiple cognitive
processes related to memory and learning such as preference
for novelty and recognition memory (Antunes and Biala, 2012;
Barker et al., 2007). However, the animals did not show any
improvement in the rotarod task, which involves a challenge to
motor balance and coordination (Figure 3C).
Analysis of the grafted brains demonstrated excellent survival
of the human cells, which were identified by immunohistochem-
istry for human nuclear antigen (hNA) or human neural cell
adhesion molecule (hNCAM). Cells were found throughout the
cerebral hemispheres with many in the corpus callosum where
they appeared aligned along the main transverse axis, similar
to host cells. Human cells were also distributed along other white
matter pathways, including the fimbria of the hippocampus and
the commissures, as shown by a series of camera lucida repre-
sentations and corresponding immunohistochemistry images
(Figure 3D). Phenotypic analysis of the surviving human cells
by confocal microscopy demonstrated that the majority are oli-
godendrocytes at various stages of maturity, expressing Olig2,
Olig1, O4, myelin-associated glycoprotein (MAG), myelin oligo-
dendrocyte-specific protein (MOSP) (Figures S4A and S4B),
andMBP. A detailed analysis of the brain sections demonstrated
significant evidence of contribution of the graft cells to remyeli-
nation and replenishment of the oligodendrocyte pool. The total
number of olig2 cells within the corpus callosum was decreased
in the irradiated rats, but replenished to near normal in the
grafted animals (control 0.64 3 106 ± 0.08; XRT 0.24 3 106 ±
0.03; XRT + Graft 0.54 3 106 ± 0.05) (Figure 3E). An average of
0.22 ± 0.013106 human cells, all expressing olig2, were counted
in the corpus callosum and 0.17 ± 0.053 106 in the hippocampi.
These data show that the restoration of olig2 is due in large part
to the addition of human cells, rather than the upregulation of
olig2 expression in endogenous progenitors. Similarly, a side-
by-side comparison of sections from the control, XRT and
XRT+ graft brains demonstrates a significant recovery of O4+
progenitors, and evidence of remyelination (Figures 3F and
3G). Imaging-based quantification of the levels of O4 and MBPdendrocyte Progenitor Cells from Human Embryonic Stem Cells
lig2+ cells in the corpus callosum in the irradiated (XRT) brain.
following radiation compared with normal control.
ibit a decrease in the exploration ratio in the novel object preference task and in
total distance travelled on the accelerating rod.
Cs.
ve stages of differentiation intomature oligodendrocytes. At day 50, early OPCs
ssing O4 together with Olig2, Nkx2.2, and forebrain specific marker FoxG1. O1
sociated glycoproteins (MOG and MAG).
re morphologically and express MBP.
cell phenotypes versus undifferentiated H9 ESCs, as assessed by microarray
odendrocyte (Olig1, Olig2, Sox10, Nkx2.2, PDGFRa, and MOG) and forebrain-
ntrol; p < 0.01, n = 3. Fold change is expressed as log2.
al low magnification images. All scale bars are 100 mm. Data are mean values ±
l nuclei are counterstained in blue with DAPI. See also Figures S1 and S2.
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Figure 2. OPCs Can Be Derived from
Different Human Pluripotent Stem Cell
Lines and Can Myelinate In Vitro
(A) Immunocytochemistry of late OPCs derived
from hES line (H7) and 2 iPS lines (J1, J2).The cells
co-express Olig2, Nkx2.2, and Sox10withO4. Day
70 O4+ cells mature into MBP- expressing oligo-
dendrocytes after 2 weeks of differentiation. Scale
bar represents 200 mm.
(B) Comparison of the efficiency of OPC derivation
by FACS for O4 across four human pluripotent
stem cell (hPSC) lines.
(C) In vitro myelination assay: co-culture of O4
sorted cells of different origins with rat hippo-
campal neurons for 5 weeks. Immunocytochem-
istry for the axonal marker SMI312 and MBP
demonstrates myelination of several axons by a
single oligodendrocyte cell. Arrows indicate fibers
that co-express both markers. Scale bar repre-
sents 50 mm.
(D) Graph represents the total length of axons with
myelin sheaths per MBP+ oligodendrocyte derived
from the hPSC lines shown.
(E) Representative electron microscopy (EM) im-
age from a co-culture of OPCs and neurons,
showing the formation of multilayered compact
myelin sheaths. Scale bar represents 500 nm.
Data are mean values ± SEM. (*p < 0.05. **p <
0.01). All nuclei are counterstained in blue with
DAPI. See also Figure S3, which includes negative
control co-cultures.confirms these observations in a statistically significant manner
(Figures 3F and 3G). The decrease in myelin, which followed a
patchy pattern, and its recovery are shown in Luxol-stained
coronal sections of various areas of the brain (Figure S4C). A ste-
reological volumetric analysis of the corpus callosum also shows
recovery to near normal volume in the grafted animals (Fig-
ure S4D). We estimated axonal density by immunohistochem-
istry for SMI312, an axonal marker (Figure S5A), and by electron
microscopy and did not note significant differences among the
animal groups (axonal density of 149.2 ± 13.55 vs 138.06 ±
11.69 vs 147.15 ± 23.01, per 100 mm2 in the control, XRT and
XRT+ graft groups respectively; p > 0.05). Similarly, a stereologi-
cal estimate of the number of neurons in the cortex did not show
changes across the animal groups (11.71 ± 1.78 3 106 in the
control vs 11.65 ± 1.09 3 106 in the XRT group, Figure S5B).
However, the proportion of axons that are ensheathed in myelin
shows a significant increase in the grafted animals, compared to
the sham treated radiation group (53%± 6% in the XRT+ graft, vs
27% ± 8% in the XRT and 62% ± 7% in the normal control, Fig-202 Cell Stem Cell 16, 198–210, February 5, 2015 ª2015 Elsevier Inc.ure 4A). These data suggest that the gain
in callosal dimensions is likely due to re-
myelination and recovery of the glial cell
population. MBP, a major component of
the myelin sheath is a complex structure
that is highly conserved across species
(Harauz and Boggs, 2013). In view of their
significant homology, MBP of rat or hu-
man origin cannot be distinguished by
any known antibody. Therefore, confirm-ing the human origin of myelin will depend on co-labeling with
human markers. Multichannel confocal imaging (Figure 4B) and
orthogonal projections (Figure 4C) show co-labeling of human fi-
bers (hNCAM) with MBP (3D reconstruction in Figure 4D; Movie
S1). Imaging of the paranodal and juxtaparanodal proteins that
define the nodes of Ranvier demonstrates reduced density and
loss of architecture following radiation, as is often reported in
demyelination conditions (Uchida et al., 2012), but significant re-
covery after grafting (Figure 4E). 3D reconstruction of confocal
optical sections showed the juxtaparanodal protein kv1.2 alter-
nating with the paranodal protein Caspr1, in appropriate ‘‘para-
nodal’’ alignment along a myelinated fiber (Gu and Gu, 2011),
with overlay of human NCAM, suggesting contribution of human
cells to the reconstruction of a node of Ranvier (Figure 4F; Movie
S2). Electron microscopy of brain sections showed areas of sig-
nificant loss of myelin or degeneration and unraveling of the
myelin sheath around the axons in the corpus callosum of the
irradiated brains. In contrast, the grafted brains exhibited evi-
dence of structural repair of the demyelinated areas with
Figure 3. Grafted Human ES-Derived OPCs
Remyelinate the Irradiated Brain and
Ameliorate Cognitive Function
(A and B) Grafted animals (n = 6) showed signifi-
cant improvement on the novel object preference
(exploration ratio) and object location tasks
(discrimination ratio) when compared to sham
grafted irradiated animals (n = 4) to normal con-
trols (n = 4).
(C) Grafted animals failed to improve on the ro-
tarod task exhibiting scores that are similar to the
irradiated sham injected group (XRT).
(D) Camera lucida representations of the distribu-
tion of human cells (marked by human nuclear
antigen, hNA, or human NCAM [hNCAM]) in a
series of coronal sections (a–d) of the brain; the
cells migrate widely along white matter paths.
Corresponding immunohistochemistry sections
demonstrate the human cells in different regions.
Cx, cortex; cc, corpus callosum; Hip, hippocam-
pus. Scale bars represent 5 mm for the camera
lucida; 100 mm for immunohistochemistry images.
(E) Immunohistochemistry (IHC) pictures and
stereological calculation of the number of Olig2+
cells in the corpus callosum of control, irradiated
(XRT), and irradiated and grafted animals (Graft).
Selected area of the grafted corpus callosum is
shown in inset at higher magnification. Scale bar
represents 100 mm.
(F and G) Representative IHC pictures and in-
tensity quantification of O4 and MBP in the CC in
control, XRT and XRT + graft rats. Selected areas
of the grafted corpus callosum are shown in insets
at higher magnification. Scale bar represents
100 mm.
All panels in (D)–(G) are composites of several low
magnification images. All nuclei are counter-
stained in blue with DAPI. Data are reported as
mean values ± SEM. (*p < 0.05. **p < 0.01). Circles
(A)–(C) represent individual scores. See also Fig-
ures S4 and S6.
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Figure 4. Quantification of Remyelination in
the Grafted Irradiated Brains
(A) Quantification of axonal ensheathment dem-
onstrates an increase in the percent myelinated
axons after grafting. Data are reported as mean
values ± SEM. *p < 0.05.
(B) Immunohistochemistry for MBP, neurofilament
(NF), and human marker (hNCAM) shows coloc-
alization of NF and MBP fibers and, in the graft
group, additional co-labeling of MBPwith hNCAM.
The arrows point to myelinated axons (co-locali-
zation of MBP and NF) and the arrow heads indi-
cate human myelin (co-localization with MBP and
hNCAM). Scale bar represents 15 mm.
(C) Confocal imaging of human cells (identified
with hNCAM) showing typical oligodendrocyte
morphology co-labeled with MBP in cytoplasm
and myelin sheath projections. Single channels
are displayed in the middle panel, with white ar-
rows identifying myelin from human origin. In the
top right panel, two oblique slicers were used on
the same field of view as the middle panel to
confirm that MBP was expressed by hNCAM-ex-
pressing cells. In the right bottom panels, three-
dimensional yz and xz orthogonal projections
were shown to confirm MBP co-labeling with
hNCAM (seen in yellow). Scale bar represents
10 mm.
(D) 3D reconstruction in high magnification of hu-
man graft cells projecting hNCAM labeled pro-
cesses (magenta) that merge with MBP (green)
along a probable axon in the cc. The MBP color
was rendered semi-transparent to enhance visu-
alization of the overlapping channels (arrows).
Scale bar represents 500 mm. See also Movie S1.
(E) Representative confocal IHC images of junx-
taparanodal protein kv1.2 and paranodal protein
Caspr1 show restoration of nodal architecture in
the grafted brain. Scale bar represents 15 mm.
(F) Triple labeling of sections of grafted irradiated
brain with hNCAM, Caspr1 (arrows) and Kv1.2
(arrowheads), indicating that human cells asso-
ciate closely with myelin fibers. Scale bar repre-
sents 10 mm. In the middle and lower panels,
representative images show co-localization of
hNCAM with the juxtaparanodal protein kv1.2
(merge as yellow) and alternating with host Caspr1
(magenta) in appropriate anatomic alignment,
likely along a myelinated axon. In the lower right
panel, 3D reconstruction performed with Bitplane
Imaris software showing the structures in
perspective. Scale bar represents 3 mm. The
drawing in the lower left panel is a schematic
representation to interpret the 3Dmodel shown on
the right side. See also Movie S2.
See also Figure S5.recovery of thin yet compact myelin sheaths wrapped around
healthy axons (Figure 5A). These findings are reflected in the
quantification (Franklin and Ffrench-Constant, 2008) of the
average g-ratio (0.70 in normal group, 0.76 in the XRT group
and 0.72 in the XRT+ graft group; Figure 5B). Immunogold elec-
tron microscopy showed integration of human NCAM into the204 Cell Stem Cell 16, 198–210, February 5, 2015 ª2015 Elsevier Incmyelin sheaths and relatively rare immunogold particles that
are not in association with myelin bundles (Figure 5C). Further
quantification of myelination by the grafted cells was performed
on IHC sections of MBP/hNCAM. The proportion of myelin of hu-
man origin in the grafted animals was calculated at 47% (area
of hNCAM+MBP+/MBP+). Taken together, these data confirm.
Figure 5. Ultrastructural Analysis of In Vivo
Myelination by Human Grafts
(A) Representative EM images of the cc show
patchy disruption of the myelin sheath around
axons in the irradiated brain. The grafted brains
show evidence of recovery of axonal myelination.
Recent sheaths are thinner in diameter though
they exhibit normal compact anatomy. Scale bar
represents 2 mm in the upper panel and 500 nm for
the two lower panels.
(B) g-ratios of the axons in corpus callosum in
control, irradiated (XRT), and irradiated+graft
(XRT+graft) groups. **p<0.01.
(C) Low power view of immuno-electron micro-
graph of hNCAM. The red arrowhead indicates
myelin sheaths of an axonal projection with
hNCAM gold labeling (10–25 nm black dots).
Green arrows indicate endogenous myelin without
immunolabeling. Scale bar represents 2 mm.that grafted human cells extensively contribute to the structural
and functional remyelination in the radiated brain. The trans-
planted cells did not promote astrogliosis or microglial/macro-
phage proliferation and activation (Figure S5C). Areas of
neurogenesis such as the subventricular zone (SVZ) and hippo-
campus were impacted by radiation as reported in the literature
(Romanko et al., 2004; Monje et al., 2002; Panagiotakos et al.,
2007). Specifically there was a loss of doublecortin-expressing
neuroblasts and proliferating cells (ki67) in the SVZ and hippo-
campus. Human cells were found in those regions but none
exhibited neuronal differentiation, nor did they promote host-
derived neurogenesis (Figures S5D and S5E). There was no
evidence of teratomas or other signs of tumor formation, and
no graft overgrowth was noted in any of the grafted animals. InCell Stem Cell 16, 198–210fact, a phenotypic analysis of the cells
did not demonstrate any Oct4, nestin, or
Ki67 co-labeling with a human marker in
the grafted brains (data not shown). As-
trocytes of human origin were very rare,
suggesting that the oligodendrocyte pro-
genitors were either terminally committed
or, less likely, that the microenvironment
was not supportive of astrocytic differen-
tiation. However, analysis of the cere-
bellum demonstrated complete absence
of human cells and persistent demyelin-
ation (Figure S5F), thus possibly explain-
ing the lack of improvement on the
rotarod acceleration tasks.
Cerebellar Grafts Rescue Motor
Coordination and Remyelinate the
Cerebellum
A second group of animals (n = 28) was
then subjected to the same radiation
regimen, and received human ES-derived
oligodendrocytes injected either in the
cerebellum alone or in combination with
the corpus callosum bilaterally. A total of
1 million cells were injected in the corpuscallosum, as in the initial study. The cerebellum received a single
injection of 250,000 O4+ sorted cells in the central white matter.
Animals were followed and tested behaviorally at two time
points, 10 and 14 weeks post-injection. Performance on the
novel object preference and object location tasks improved
significantly in the group that received callosal and cerebellar
grafts when compared to the non-transplanted animals, while
the animals with grafts only in the cerebellum did not improve
in any of the tests probing cognitive skills (Figure S6A). However,
all grafted animals showed improvement in the rotarod task,
including those that received cerebellar only injections (Fig-
ure 6A). Histological analysis of the brains demonstrated survival
and migration of the human cells in the cerebellum (Figure 6B).
There was also evidence of remyelination of the cerebellum in, February 5, 2015 ª2015 Elsevier Inc. 205
Figure 6. Cerebellar Grafts Rescue Motor Coordination and Remyelinate the Cerebellum
(A) Grafted animals showed improvement on the accelerating rotarod tasks (n = 6).
(B) Representative camera lucida illustration of the distribution of human cells in the cerebellum, detected by IHC for human nuclear antigen (hNA). Scale bar
represents 1mm.
(C) Representative Luxol fast blue staining of sagittal sections of the cerebellum and IHC images showingmyelin loss in the XRT group and recovery upon grafting.
Human cells (hNA) co-label with olig2, O4, and MBP. Scale bar represents 0.5 mm in the luxol images and 100 mm in the IHC images.
(D) Quantification of O4 and MBP image intensity in the white matter of cerebellum.
(E) Human-specific MBP mRNA was detectable in the grafted group, as well as the human ESC-derived oligodendrocytes and the normal human cerebellum
tissue (hCb). Expression levels of human NCAM and MBP (human and rat) mRNA are also analyzed as reference. The relative expression of mRNA was
normalized to human OPCs. N.D., non detectable.
Data in (A), (D), and (E) are reported as mean values ± SEM with the indicated significance (*p < 0.05, **p < 0.01). See also Figure S6.all grafted animals as assessed by Luxol histochemistry and
quantitative immunofluorescence for olig2, O4, and MBP (Fig-
ures 6C and 6D). Animals that received cell injections in the cer-
ebellum only did not exhibit remyelination in the corpus callosum
or elsewhere in the cerebral hemispheres. There was no evi-
dence for endogenous or human astrogliosis, excessive prolifer-
ation, or teratomas. To further support the role of human cell-
mediated structural repair, we performed qRT-PCR to confirm206 Cell Stem Cell 16, 198–210, February 5, 2015 ª2015 Elsevier Incthe presence of myelin of human origin in the grafted tissue.
The data demonstrate the expression of a human-specific
MBP mRNA isoform in the grafted rat tissue, normal human cer-
ebellum, and human ESC-derived oligodendrocytes, but not in
the control or irradiated rat brains (Figure 6E). Expression of hu-
man NCAM and MBP (recognizing both human and rat) mRNA
were also detected in the same samples as reference. These
data provide strong evidence for structural repair of the.
demyelinated irradiated brain via human ES-derived oligoden-
drocytes, leading to behavioral recovery that is specific to the re-
myelinated region of the brain.
DISCUSSION
As intense efforts in cancer therapies succeed in achieving long
periods of remission and hopes of long-term survival, a focus on
improving quality of life among survivors is more pressing. Radi-
ation damage to the brain ranks among the major contributors to
poor quality of life and is currently untreatable (Van Dongen-Mel-
man et al., 1997; Yabroff et al., 2004). Here we demonstrate that
remyelination of the irradiated brain via grafting of human oligo-
progenitors can lead to cognitive and motor amelioration. Our
model holds particular promise in view of the substantial and
clinically relevant dose of fractionated radiation used, 50 Gy.
There are reports of repair of radiation-induced demyelination,
e.g., in the spinal cord, though the animal models used often
received a single dose of radiation (Sun et al., 2013). Here we
have focused on modeling whole-brain or large-volume radia-
tion, rather than single high-dose focal radiation. Available clin-
ical regimens are highly variable depending on the disease being
treated. Commonly, whole-brain or large-volume partial brain ra-
diation involves the delivery of 30–60 Gy in multiple fractions. It is
difficult to fully mimic the human regimens. In particular, the dose
per fraction we used is higher than average, largely due to logis-
tical reasons, because the rodents have to be fully anesthesized
for each dose of radiation.
Radiation injury is a complex phenomenon with a myriad of
direct and indirect consequences, such as an impact on
the vascular compartment, glia, local inflammatory systems,
neurogenesis, and altered neuronal function (Bentzen, 2006;
Greene-Schloesser et al., 2013). Recent reports have shown
improvement of cognitive tasks following injection of neural
stem cells in the hippocampus of irradiated rats, though the ra-
diation regimen was subtherapeutic (Acharya et al., 2014). It is
unclear to what extent rescue of hippocampal neurogenesis
would contribute to symptom amelioration in humans. Despite
the absence of neuronal differentiation by our cells and the
decreased neurogenesis in the hippocampus following radiation,
the animals exhibited improvement in cognition and in motor
function, suggesting an important role for white matter recovery.
The correlation of behavioral amelioration with the site of cell in-
jection and area of remyelination support cell-mediated repair,
though the possibility of a favorable paracrine role for the grafted
cells cannot be completely excluded.
We also present a robust protocol for the derivation of highly
enriched fully committed oligodendrocytes from human ESCs
or iPSCs, capable of widespreadmigration and efficient myelina-
tion with near complete absence of other phenotypes and
no evidence for proliferative cell types, primitive progeny, or
teratomas. Such an approach can be fully GMP-compatible in-
cluding the sorting step, though further acceleration of the
in vitro period would be desirable. Pluripotent stem cells (PSC)
are also an attractive cell source given their scalability, at the
level of the undifferentiated cells which are readily expandable,
as well as during the differentiation process. We estimate based
on numerous replications of this protocol, that starting with 10
million undifferentiated hESCs (a few vials), we can obtain aboutCe214 million well characterized O4+ cells at day 100 of culture
(assuming an O4+ recovery rate of 35%). A main limiting factor
for PSC-based cell therapies is often the ability to direct their
differentiation into authentic and stable phenotypes. This is a
particularly challenging task if the cells of interest develop late
or need to be fully functional prior to transplantation. Here, we
present a reliable differentiation strategy with stable phenotypes
that closely resemble current definitions of oligodendrocyte
progenitors (markers, gene-expression profile). In vivo, the
overwhelming majority of the cells develops into mature myeli-
nating oligodendrocytes or remains in the oligoprogenitor stage.
We rarely identify any other phenotypes and there were no
teratomas or areas of graft overgrowth, though assessments
following longer in vivo periods, such as one year or longer,
should be performed. Our strategy also includes a sorting step,
which not only enriches for the phenotype of interest, but also
presents an opportunity for indirectly selecting out undifferenti-
ated ESCs, which are a source of safety concerns. A more
aggressive negative selection approach can also be contem-
plated, but to our knowledge, it has not been a strict prerequisite
for FDA approval of pluripotent stem cell based therapies. On the
other hand, the differentiation protocol remains rather lengthy
and will need to be optimized further for logistical purposes, if
GMP manufacturing is planned.
Other human cell sources have been used successfully for re-
myelination in rodent models, such as fetal or adult white-matter
progenitors (Windrem et al., 2004) though access to these cell
sources can be difficult, especially because the cells need to
be replenished because they are not highly expandable. The
FDA has also approved early phase trials of multiply passaged
multipotent neural stem cells isolated from fetal brain (Uchida
et al., 2012; Gupta et al., 2012). These cells, manufactured to a
clinical grade, have been used for a wide range of disorders (Pel-
izaeus-Merzbacher disease, neuronal ceroid lipofuscinosis, and
spinal cord injury; see https://clinicaltrials.gov/). The cells are
thought to provide a very beneficial neuroprotective effect.
The requirement for immunosuppression is another important
issue in planning for clinical applications, though it remains the
subject of debate. The preponderance of available data points
towards the need for at least temporary immunosuppression at
the time of surgical injection. The specific agents to be used
and the total duration of treatment are also highly variable
(Tadesse et al., 2014). In the case of radiation injury, immuno-
suppression could increase the burden of treatment-related
morbidities, though most patients already receive far harsher
chemotherapeutic agents. On the other hand, the derivation of
engraftable oligoprogenitors from iPSCs is robust and feasible,
as shown by our group and others; the majority of cancer pa-
tients can safely provide genetically normal somatic cells, such
as skin, for iPS production, thereby developing a customized
autologous cell source. However, there remain significant regu-
latory hurdles, as well as some scientific concerns, over the
clinical use of iPSCs, despite their recent approval in Japan for
the treatment of Parkinson’s disease.
In summary, our results suggest that countering the cognitive
side effects of radiation injury can be achieved safely, using hu-
man pluripotent cell-derived oligodendrocytes, thus paving the
road towards a clinical trial for a condition that currently has no
viable therapeutic options. The protocol could also be readilyll Stem Cell 16, 198–210, February 5, 2015 ª2015 Elsevier Inc. 207
adapted to other demyelination disorders and, although further
long term data will be required, these results represent a
robust first set of preclinical studies, with an eye towards future
translation.
EXPERIMENTAL PROCEDURES
Animals, X-Irradiation, and Cell Transplantation
Female Athymic nude rats (RNU rat Crl:NIH-Foxn1rnu, Charles River Labora-
tories) aged 4 weeks were randomized into three age-matched groups:
non-irradiated (‘‘control’’ rats, n = 16 in total), irradiated rats with sham trans-
plantation of HBSS (XRT, n = 17 in total), and irradiated rats transplanted with
human ESC-derived OPCs (XRT + graft, n = 18 in total). Radiation was admin-
istered to the cranium using a 250 kV-orthovoltage system. Animals were
anesthetized by ketamine (90 mg/kg)/xylazine (4 mg/kg) and placed on a
custom-designed positioning platform covered with a protective lead plate
with an adjustable aperture, which focuses the radiation delivery to the skull
while shielding the rest of the body. A total dose of 50 Gy was administered
in 10 fractions (5 Gy/fraction/day), over 2 weeks. One month after irradiation,
human cells were transplanted into the corpus callosum, in 2 injections of
250,000 cells in each hemisphere, for a total of 1 million cells (Coordinates:
AP 0.40 mm, ML 2.4 mm, VRT 3 mm; AP 0.40 mm, ML 2.4 mm, VRT
3 mm; AP 1.30 mm, ML –2 mm, VRT 3.2 mm; AP 1.30 mm, ML 2 mm,
VRT 3.2 mm; tooth bar set at 0). Cerebellar injections were performed unilat-
erally into the cerebellar white matter and consisted of 250,000 cells delivered
stereotactically (Coordinates: AP 12 mm, ML –0.9 mm, VRT 4.2 mm; tooth
bar set at 0). The rats were anaesthetized with Ketamine/xylazine during the
surgical procedures. Cells were delivered via a Hamilton Syringe (Hamilton
Company) on a stereotactic Kopf frame (David Kopf Instruments). All animal
procedures and care were performed according to NIH guidelines and
following IACUC approval.
Human ESC-Derived Oligodendrocyte Precursor Cell Culture
Human ESCs (WA-09, XX, passages 35–45) were cultured on mouse embry-
onic fibroblasts (MEFs, GlobalStem) in medium of DMEM/F12 containing
20% knockout serum replacement (Gibco), 0.1 mM b-mercaptoethanol, and
6 ng/ml FGF-2 (R&DSystems). hESCs and iPSCs were used according to insti-
tutional ESCRO guidelines and approval.
Neural Induction
For neural induction, a modified version of the dual-SMAD inhibition was used.
Undifferentiated hESCs were disaggregated using Accutase (Innovative Cell
Technology) and plated on on Matrigel (BD Bioscience)-coated dishes at a
density of 40,000 cells/cm2 in MEF conditioned hESC medium supplemented
with 10 ng/ml of FGF-2 and Y-27632 (10mM, Tocris Bioscience). When the cells
reached a confluent state (2–3 days after plating), they were exposed for
9 days to LDN193189 (200nM, Stemgent) and SB431542 (10 mM, Tocris) in
knockout serum replacement medium (KSR) containing DMEM, 15%
knockout serum replacement, 2 mM L-glutamine and 10 mM b-mercaptoetha-
nol. Starting from day 5, Purmorphamine (1 mM, Stemgent) was added to dif-
ferentiation media. KSR medium was gradually replaced with N2 medium
(25%, 50%, 75%) starting on day 4 of differentiation as described previously
(Chambers et al., 2009).
Patterning and Differentiation of Oligodendrocytes
On day 12, cells were dissociated using Accutase and replated in high-den-
sity conditions (300,000 cells per cm2) on dishes precoated with polyorni-
thine (PO; 15 mg/ml), laminin (Lam; 1 mg/ml) and fibronectin (FN; 2 mg/ml) in
N2 medium supplemented with brain-derived neurotrophic factor (BDNF;
20 ng/ml, R&D), ascorbic acid (AA; 0.2 mM, Sigma-Aldrich), Purmorphamine
(1 uM, Stemgent) and fibroblast growth factor 8 (FGF8; 100 mg/ml, R&D).
They are patterned at the P1 stage for 2 weeks. After two weeks of
patterning, cells were passaged by mechanical picking of the CNS clusters
and re-plated on PO/Lam/FN coated dishes (P2). Starting with P3, neural
precursor cells (NPCs) were maintained in N2/B27 medium supplemented
with Purmorphamine and FGF8 until day 40 when they were further exposed
to glial media containing platelet-derived growth factor (PDGF; 20 ng/ml,
R&D), insulin-like growth factor 1 (IGF-1; 20 ng/ml, R&D), triiodothyronine
(T3; 20 ng/ml, Sigma-Aldrich) and dibutyryl cAMP (0.1 mM, Sigma-Aldrich).208 Cell Stem Cell 16, 198–210, February 5, 2015 ª2015 Elsevier IncMedium was changed every 2 days, whereas the cultures were passaged
every 2 weeks.
Microarray Analysis
For microarray analysis, total RNA from undifferentiated hESCs (control con-
dition) and 70 days old, O4 sorted OPCs was collected using Trizol LS (Invi-
trogen). Samples were processed by the MSKCC Genomic core facility and
hybridized on Illumina Human HT-12 Oligonucleotide arrays (total of 34,694
genes). Gene-expression analysis was done with the Partek Genomics Suite.
Genes that had an adjusted p value < 0.05 and a fold change greater than
two were considered significant. Raw data for the microarray gene expres-
sion reported in this study are available from the public repository of GEO
Data Sets (accession number GSE63318). Top enriched gene groups were
obtained using Gene Ontology enrichment analysis (DAVID) and are pre-
sented as a function of the corresponding Benjamini–Hochberg FDR cor-
rected p values.
In Vitro Myelination Assay
hESC-derived neural stem cells were generated using a modified dual SMAD
inhibition protocol (Chambers et al., 2009). Differentiation of neurons from
NSCs was achieved by seeding the NSCs at low density in N2mediumwithout
growth factors. Nearly homogenous populations of neurons were generated
within 30 days and used for co-culture experiments. Hippocampal neurons
were isolated from postnatal day 1 SD rats (Gardner et al., 2012).
Human ES-derived neuronal cells and rat hippocampal neurons were co-
cultured with human PSC-derived OPCs sorted for O4 on poly-O-ornithine
(50 mg/ml) and laminin (1mg/ml) coated wells in Neurobasal medium (Life Tech-
nologies) with B27 (Life Technologies), GlutaMAX-I Supplement (2 mM, Life
Technologies), BDNF (20 ng/ml), AA (0.2 mM), T3 (60 ng/ml, Sigma-Aldrich),
and cAMP (0.2 mM, Sigma-Aldrich) for 4 weeks and 5 weeks, respectively.
Myelination was identified as co-labeling of SMI312 (axons) and MBP (oligo-
dendrocyte processes). The length of axons was measured according to the
method described by Deshmukh et al. (2013) with minor modifications. In
our experiments, myelination was identified as regions of co-localization
between MBP-positive oliogodendrocyte processes and SMI312-positive
neuritis, and the length was measured with the NIH ImageJ software. This
measurement was analyzed in ten randomly chosen fields from replicate co-
culture samples. For the EM studies the co-cultures were maintained for
7 weeks. The differentiation medium was changed twice a week.
Behavioral Testing
We used the novel object-preference task and novel place-recognition tests,
modified from Barker et al. (Barker et al., 2007). An open field arena (TSE
Systems) was used for testing. During the testing, the time to explore the ob-
jects was recorded and analyzed by Videomot2 (TSE Systems). In brief, for
novel object-preference task, rats were allowed to habituate twice in the
arena with two identical objects for 5 minutes. Then the rats were placed
in the arena for 3 minutes with one novel object and one familiar object.
The data was presented as exploration ratio or ratio of time spent exploring
the novel object versus both objects. For the object-location task, the rats
were habituated to two identical objects for 10 minutes. Then they were
placed in the arena with one object moved to a new location (novel place)
and another identical object remaining in the same position (familiar place)
for 3 minutes. The data was presented as discrimination ratio = (time
exploring the object in the novel place  the familiar place) / time spent
exploring both objects. The Morris water maze test was performed as
described by Vorhees et al. (Vorhees and Williams, 2006). An automated ro-
tarod treadmill (7 cm diameter rod, IITC Life Science Inc.) was used in the
rotarod analysis. The rats were pre-trained to learn to run on a rotating rod
at 5 rpm and 10 rpm prior to testing. The rotarod was accelerated from 15
to 40 rpm over 60 seconds for the analysis. The length of time and distance
traveled until the rats fell off the rod were recorded.
Statistics
Results are expressed as the mean ± SEM. The statistical analysis was per-
formed using IBM SPSS Statistics (version 21) software. Normality was tested
by Shapiro-Wilk test. Statistical analysis was performed by ANOVA. Homoge-
neity of variance was tested. p% 0.05 was considered to denote significance..
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